CNTB
Connect Biopharma Holdings Ltd (CNTB)
Healthcare • NASDAQ • $2.36+1.29%
Key Fundamentals
- Symbol
- CNTB
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $2.36
- Daily Change
- +1.29%
- Market Cap
- $133.39M
- Trailing P/E
- N/A
- Forward P/E
- -2.34
- 52W High
- $3.82
- 52W Low
- $0.70
- Analyst Target
- $7.90
- Dividend Yield
- N/A
- Beta
- N/A
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Company websiteResearch CNTB on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.